USA Biologics & Biosimilars Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Biologics & Biosimilars market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Biologics & Biosimilars market. Detailed analysis of key players, along with key growth strategies adopted by Biologics & Biosimilars industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Amgen

    • Roche

    • AbbVie

    • Novartis

    • Lilly

    • Hospira

    • Changchun High Tech

    • Sanofi

    • Mylan

    • CP Guojian Pharmacy

    • Biotech Pharma

    • Novo Nordisk

    • Gelgen Biopharma

    • fizer

    • 3sbio

    • Johnson & Johnson

    • Merck

    • Teva

    • Sandoz

    By Type:

    • Antibiotic

    • Enzyme

    • Hormone

    • Non-Patented Biological Reagents

    • Other

    By End-User:

    • Tumor

    • Diabetes

    • Cardiovascular

    • Hemophilia

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biologics & Biosimilars Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Biologics & Biosimilars Market Size and Growth Rate of Antibiotic from 2016 to 2027

      • 1.3.2 USA Biologics & Biosimilars Market Size and Growth Rate of Enzyme from 2016 to 2027

      • 1.3.3 USA Biologics & Biosimilars Market Size and Growth Rate of Hormone from 2016 to 2027

      • 1.3.4 USA Biologics & Biosimilars Market Size and Growth Rate of Non-Patented Biological Reagents from 2016 to 2027

      • 1.3.5 USA Biologics & Biosimilars Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Biologics & Biosimilars Market Size and Growth Rate of Tumor from 2016 to 2027

      • 1.4.2 USA Biologics & Biosimilars Market Size and Growth Rate of Diabetes from 2016 to 2027

      • 1.4.3 USA Biologics & Biosimilars Market Size and Growth Rate of Cardiovascular from 2016 to 2027

      • 1.4.4 USA Biologics & Biosimilars Market Size and Growth Rate of Hemophilia from 2016 to 2027

      • 1.4.5 USA Biologics & Biosimilars Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Biologics & Biosimilars Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biologics & Biosimilars by Major Types

      • 3.4.1 Market Size and Growth Rate of Antibiotic

      • 3.4.2 Market Size and Growth Rate of Enzyme

      • 3.4.3 Market Size and Growth Rate of Hormone

      • 3.4.4 Market Size and Growth Rate of Non-Patented Biological Reagents

      • 3.4.5 Market Size and Growth Rate of Other

    4 Segmentation of Biologics & Biosimilars Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biologics & Biosimilars by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biologics & Biosimilars in Tumor

      • 4.4.2 Market Size and Growth Rate of Biologics & Biosimilars in Diabetes

      • 4.4.3 Market Size and Growth Rate of Biologics & Biosimilars in Cardiovascular

      • 4.4.4 Market Size and Growth Rate of Biologics & Biosimilars in Hemophilia

      • 4.4.5 Market Size and Growth Rate of Biologics & Biosimilars in Other

    5 Market Analysis by Regions

    • 5.1 USA Biologics & Biosimilars Production Analysis by Regions

    • 5.2 USA Biologics & Biosimilars Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Biologics & Biosimilars Landscape Analysis

    • 6.1 West USA Biologics & Biosimilars Landscape Analysis by Major Types

    • 6.2 West USA Biologics & Biosimilars Landscape Analysis by Major End-Users

    7 South USA Biologics & Biosimilars Landscape Analysis

    • 7.1 South USA Biologics & Biosimilars Landscape Analysis by Major Types

    • 7.2 South USA Biologics & Biosimilars Landscape Analysis by Major End-Users

    8 Middle West USA Biologics & Biosimilars Landscape Analysis

    • 8.1 Middle West USA Biologics & Biosimilars Landscape Analysis by Major Types

    • 8.2 Middle West USA Biologics & Biosimilars Landscape Analysis by Major End-Users

    9 Northeast USA Biologics & Biosimilars Landscape Analysis

    • 9.1 Northeast USA Biologics & Biosimilars Landscape Analysis by Major Types

    • 9.2 Northeast USA Biologics & Biosimilars Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Amgen

        • 10.1.1 Amgen Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Roche

        • 10.2.1 Roche Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 AbbVie

        • 10.3.1 AbbVie Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Novartis

        • 10.4.1 Novartis Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Lilly

        • 10.5.1 Lilly Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Hospira

        • 10.6.1 Hospira Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Changchun High Tech

        • 10.7.1 Changchun High Tech Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Sanofi

        • 10.8.1 Sanofi Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Mylan

        • 10.9.1 Mylan Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 CP Guojian Pharmacy

        • 10.10.1 CP Guojian Pharmacy Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Biotech Pharma

        • 10.11.1 Biotech Pharma Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Novo Nordisk

        • 10.12.1 Novo Nordisk Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Gelgen Biopharma

        • 10.13.1 Gelgen Biopharma Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 fizer

        • 10.14.1 fizer Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 3sbio

        • 10.15.1 3sbio Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

      • 10.16 Johnson & Johnson

        • 10.16.1 Johnson & Johnson Company Profile and Recent Development

        • 10.16.2 Market Performance

        • 10.16.3 Product and Service Introduction

      • 10.17 Merck

        • 10.17.1 Merck Company Profile and Recent Development

        • 10.17.2 Market Performance

        • 10.17.3 Product and Service Introduction

      • 10.18 Teva

        • 10.18.1 Teva Company Profile and Recent Development

        • 10.18.2 Market Performance

        • 10.18.3 Product and Service Introduction

      • 10.19 Sandoz

        • 10.19.1 Sandoz Company Profile and Recent Development

        • 10.19.2 Market Performance

        • 10.19.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Biologics & Biosimilars Market Size and Growth Rate of Antibiotic from 2016 to 2027

    • Figure USA Biologics & Biosimilars Market Size and Growth Rate of Enzyme from 2016 to 2027

    • Figure USA Biologics & Biosimilars Market Size and Growth Rate of Hormone from 2016 to 2027

    • Figure USA Biologics & Biosimilars Market Size and Growth Rate of Non-Patented Biological Reagents from 2016 to 2027

    • Figure USA Biologics & Biosimilars Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Biologics & Biosimilars Market Size and Growth Rate of Tumor from 2016 to 2027

    • Figure USA Biologics & Biosimilars Market Size and Growth Rate of Diabetes from 2016 to 2027

    • Figure USA Biologics & Biosimilars Market Size and Growth Rate of Cardiovascular from 2016 to 2027

    • Figure USA Biologics & Biosimilars Market Size and Growth Rate of Hemophilia from 2016 to 2027

    • Figure USA Biologics & Biosimilars Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Biologics & Biosimilars Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Biologics & Biosimilars

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biologics & Biosimilars by Different Types from 2016 to 2027

    • Table Consumption Share of Biologics & Biosimilars by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Antibiotic

    • Figure Market Size and Growth Rate of Enzyme

    • Figure Market Size and Growth Rate of Hormone

    • Figure Market Size and Growth Rate of Non-Patented Biological Reagents

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Biologics & Biosimilars by Different End-Users from 2016 to 2027

    • Table Consumption Share of Biologics & Biosimilars by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Tumor

    • Figure Market Size and Growth Rate of Diabetes

    • Figure Market Size and Growth Rate of Cardiovascular

    • Figure Market Size and Growth Rate of Hemophilia

    • Figure Market Size and Growth Rate of Other

    • Table USA Biologics & Biosimilars Production by Regions

    • Table USA Biologics & Biosimilars Production Share by Regions

    • Figure USA Biologics & Biosimilars Production Share by Regions in 2016

    • Figure USA Biologics & Biosimilars Production Share by Regions in 2021

    • Figure USA Biologics & Biosimilars Production Share by Regions in 2027

    • Table USA Biologics & Biosimilars Consumption by Regions

    • Table USA Biologics & Biosimilars Consumption Share by Regions

    • Figure USA Biologics & Biosimilars Consumption Share by Regions in 2016

    • Figure USA Biologics & Biosimilars Consumption Share by Regions in 2021

    • Figure USA Biologics & Biosimilars Consumption Share by Regions in 2027

    • Table West USA Biologics & Biosimilars Consumption by Types from 2016 to 2027

    • Table West USA Biologics & Biosimilars Consumption Share by Types from 2016 to 2027

    • Figure West USA Biologics & Biosimilars Consumption Share by Types in 2016

    • Figure West USA Biologics & Biosimilars Consumption Share by Types in 2021

    • Figure West USA Biologics & Biosimilars Consumption Share by Types in 2027

    • Table West USA Biologics & Biosimilars Consumption by End-Users from 2016 to 2027

    • Table West USA Biologics & Biosimilars Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Biologics & Biosimilars Consumption Share by End-Users in 2016

    • Figure West USA Biologics & Biosimilars Consumption Share by End-Users in 2021

    • Figure West USA Biologics & Biosimilars Consumption Share by End-Users in 2027

    • Table South USA Biologics & Biosimilars Consumption by Types from 2016 to 2027

    • Table South USA Biologics & Biosimilars Consumption Share by Types from 2016 to 2027

    • Figure South USA Biologics & Biosimilars Consumption Share by Types in 2016

    • Figure South USA Biologics & Biosimilars Consumption Share by Types in 2021

    • Figure South USA Biologics & Biosimilars Consumption Share by Types in 2027

    • Table South USA Biologics & Biosimilars Consumption by End-Users from 2016 to 2027

    • Table South USA Biologics & Biosimilars Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Biologics & Biosimilars Consumption Share by End-Users in 2016

    • Figure South USA Biologics & Biosimilars Consumption Share by End-Users in 2021

    • Figure South USA Biologics & Biosimilars Consumption Share by End-Users in 2027

    • Table Middle West USA Biologics & Biosimilars Consumption by Types from 2016 to 2027

    • Table Middle West USA Biologics & Biosimilars Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Biologics & Biosimilars Consumption Share by Types in 2016

    • Figure Middle West USA Biologics & Biosimilars Consumption Share by Types in 2021

    • Figure Middle West USA Biologics & Biosimilars Consumption Share by Types in 2027

    • Table Middle West USA Biologics & Biosimilars Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Biologics & Biosimilars Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Biologics & Biosimilars Consumption Share by End-Users in 2016

    • Figure Middle West USA Biologics & Biosimilars Consumption Share by End-Users in 2021

    • Figure Middle West USA Biologics & Biosimilars Consumption Share by End-Users in 2027

    • Table Northeast USA Biologics & Biosimilars Consumption by Types from 2016 to 2027

    • Table Northeast USA Biologics & Biosimilars Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Biologics & Biosimilars Consumption Share by Types in 2016

    • Figure Northeast USA Biologics & Biosimilars Consumption Share by Types in 2021

    • Figure Northeast USA Biologics & Biosimilars Consumption Share by Types in 2027

    • Table Northeast USA Biologics & Biosimilars Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Biologics & Biosimilars Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Biologics & Biosimilars Consumption Share by End-Users in 2016

    • Figure Northeast USA Biologics & Biosimilars Consumption Share by End-Users in 2021

    • Figure Northeast USA Biologics & Biosimilars Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lilly

    • Figure Sales and Growth Rate Analysis of Lilly

    • Figure Revenue and Market Share Analysis of Lilly

    • Table Product and Service Introduction of Lilly

    • Table Company Profile and Development Status of Hospira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira

    • Figure Sales and Growth Rate Analysis of Hospira

    • Figure Revenue and Market Share Analysis of Hospira

    • Table Product and Service Introduction of Hospira

    • Table Company Profile and Development Status of Changchun High Tech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changchun High Tech

    • Figure Sales and Growth Rate Analysis of Changchun High Tech

    • Figure Revenue and Market Share Analysis of Changchun High Tech

    • Table Product and Service Introduction of Changchun High Tech

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of CP Guojian Pharmacy

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CP Guojian Pharmacy

    • Figure Sales and Growth Rate Analysis of CP Guojian Pharmacy

    • Figure Revenue and Market Share Analysis of CP Guojian Pharmacy

    • Table Product and Service Introduction of CP Guojian Pharmacy

    • Table Company Profile and Development Status of Biotech Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotech Pharma

    • Figure Sales and Growth Rate Analysis of Biotech Pharma

    • Figure Revenue and Market Share Analysis of Biotech Pharma

    • Table Product and Service Introduction of Biotech Pharma

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Gelgen Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gelgen Biopharma

    • Figure Sales and Growth Rate Analysis of Gelgen Biopharma

    • Figure Revenue and Market Share Analysis of Gelgen Biopharma

    • Table Product and Service Introduction of Gelgen Biopharma

    • Table Company Profile and Development Status of fizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of fizer

    • Figure Sales and Growth Rate Analysis of fizer

    • Figure Revenue and Market Share Analysis of fizer

    • Table Product and Service Introduction of fizer

    • Table Company Profile and Development Status of 3sbio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3sbio

    • Figure Sales and Growth Rate Analysis of 3sbio

    • Figure Revenue and Market Share Analysis of 3sbio

    • Table Product and Service Introduction of 3sbio

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Sandoz

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz

    • Figure Sales and Growth Rate Analysis of Sandoz

    • Figure Revenue and Market Share Analysis of Sandoz

    • Table Product and Service Introduction of Sandoz


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.